MARKET

PVLA

PVLA

Palvella Therapeutics Inc
NASDAQ
145.77
-0.81
-0.55%
After Hours: 145.77 0 0.00% 16:15 11/19 EST
OPEN
146.44
PREV CLOSE
146.58
HIGH
150.80
LOW
144.25
VOLUME
150.43K
TURNOVER
--
52 WEEK HIGH
179.95
52 WEEK LOW
72.23
MARKET CAP
2.13B
P/E (TTM)
-26.5282
1D
5D
1M
3M
1Y
5Y
1D
Palvella Therapeutics Announces QTORIN Docetaxel for Rare Skin Cancer
TipRanks · 16h ago
Leerink Partners Initiates Coverage of Palvella Therapeutics at Outperform
NASDAQ · 3d ago
Yeti downgraded, Humana upgraded: Wall Street’s top analyst calls
TipRanks · 3d ago
Palvella Therapeutics Price Target Announced at $228.00/Share by Leerink Partners
Dow Jones · 3d ago
Leerink bullish on Palvella Therapeutics, initiates with an Outperform
TipRanks · 3d ago
Palvella Therapeutics initiated with an Outperform at Leerink
TipRanks · 3d ago
Weekly Report: what happened at PVLA last week (1109-1113)?
Weekly Report · 3d ago
Palvella Therapeutics Earnings Call Signals Rare-Disease Launch Momentum
TipRanks · 5d ago
More
About PVLA
Palvella Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing therapies to treat patients suffering from serious, rare genetic skin diseases for which there are no FDA-approved therapies. The Company is developing a pipeline of product candidates based on its patented QTORIN platform, with an initial focus on serious, rare genetic skin diseases, many of which are lifelong in nature. Its QTORIN product candidates are developed to accommodate the cargo at high concentrations in order to drive sufficient drug to its target deep in the epidermis and dermis. The Company's lead product candidate, QTORIN 3.9% rapamycin anhydrous gel (QTORIN rapamycin), is being evaluated in the Phase III SELVA clinical trial in microcystic lymphatic malformations and the Phase II TOIVA clinical trial in cutaneous venous malformations.

Webull offers Palvella Therapeutics Inc stock information, including NASDAQ: PVLA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PVLA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PVLA stock methods without spending real money on the virtual paper trading platform.